Skip to content
RDL Network logo
824P Patterns of response/progression and management following progressive disease (PD) with anti-PD-(L)1 (PD(L)1) in patients (pts) with advanced Merkel cell carcinoma (MCC) — Jeremy Mo (2022) | RDL Network